American Association for Cancer Research (AACR) Deploys Collexis’ Reviewer Finder and Journal Dashboard Applications

February 18, 2009

Reviewer Finder to Speed up the Peer Review Process

COLUMBIA, SC – February 18, 2009 – Collexis Holdings Inc. (OTCBB:  CLXS), a leading developer of semantic search and knowledge discovery software, announced today that the American Association for Cancer Research (AACR) has licensed the Collexis’ Reviewer Finder and Journal Dashboard applications for the six AACR cancer research journals.  

“The Collexis Review Finder application will certainly enhance and improve our peer review process as we continuously strive to target the most appropriate reviewers,” stated Diane Scott-Lichter, publisher of AACR.  “The Journal Dashboard will provide us with key insights concerning the positioning of our journals in the area of cancer research.” 

“Having the AACR sign up for our Reviewer Finder application is quite gratifying for us since AACR is the first society to adopt the Reviewer Finder for the publishing process – until today most of the Reviewer Finder customers were other funding organizations like the NHLBI at the NIH and the Wellcome Trust” said Christian Herzog, MD, Managing Director of the Collexis STM Business Unit.  As the AACR begins to use the Journal Dashboards as journal portfolio analysis tools, we are very confident that it will help them to sharpen the profile of their journals.”

The Collexis Reviewer Finder helps publishing organizations in two very important ways: first it assists in reducing the time to identify the most qualified reviewers from hours to virtually minutes by automatically suggesting best matching reviewers for a manuscript, secondly it enhances security by identifying potential conflicts of reviewers based on co-authorship and institutional affiliation. The Collexis Reviewer Finder will be integrated into the publishing workflow solution that AACR is using.

The Collexis Journal Dashboard is providing the customer a complex view to analyze the portfolio of a journal, to compare it on a granular basis to others, to understand author patterns and emerging trends – providing insights for strategic decisions on positioning and further development.

 

About Collexis Holdings, Inc.

Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with operations in Cincinnati, Ohio  and Cologne, Germany.  Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com

Collexis’ proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.”

Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect.

Collexis’ current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense.

Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.